Oral Antibiotics for Impetigo
For impetigo, first-line oral antibiotics are dicloxacillin (250 mg four times daily) or cephalexin (250 mg four times daily) in adults, targeting both Staphylococcus aureus and Streptococcus pyogenes. 1, 2, 3
Treatment Algorithm
Adults - First-Line Options:
- Dicloxacillin: 250 mg four times daily orally
- Cephalexin: 250 mg four times daily orally
- Amoxicillin-clavulanate: 875/125 mg twice daily orally
Adults - Alternative Options (if penicillin allergy or resistance concerns):
- Clindamycin: 300-400 mg three times daily orally
- Erythromycin: 250 mg four times daily orally (note: resistance rates are increasing in both S. aureus and S. pyogenes) 1, 2
Children - First-Line Options:
- Cephalexin: 25-50 mg/kg/day in 3-4 divided doses orally
- Dicloxacillin: 12-25 mg/kg/day in 4 divided doses orally (less commonly used in pediatrics)
- Amoxicillin-clavulanate: 25 mg/kg/day (of amoxicillin component) in 2 divided doses orally
Children - Alternative Options:
- Clindamycin: 20 mg/kg/day in 3 divided doses orally
- Erythromycin: 40 mg/kg/day in 4 divided doses orally (with resistance caveat) 1, 2, 3
When to Use Oral vs. Topical Antibiotics
Reserve oral antibiotics for:
- Extensive disease (multiple lesions or large affected areas)
- Bullous impetigo
- Failure of topical therapy after 3-5 days
- Outbreaks requiring rapid infection control
- Situations where topical application is impractical 4, 5
Use topical therapy (mupirocin 2% or retapamulin 1% ointment) for:
Duration of Treatment
Treat for approximately 7 days, adjusting based on clinical response 1, 2. Some evidence suggests 5-day courses may be adequate, but 7-10 days is standard practice 5, 6.
Critical Considerations
Resistance Patterns:
The guidelines note that some strains of S. aureus and S. pyogenes may be resistant to erythromycin 1, 2. This is increasingly problematic, making macrolides less reliable as first-line agents 5.
MRSA Coverage:
If community-acquired MRSA is suspected (treatment failure, known local prevalence, or purulent lesions):
- Trimethoprim-sulfamethoxazole: 1-2 double-strength tablets twice daily (adults) or 8-12 mg/kg/day based on trimethoprim component in 2 divided doses (children)
- Doxycycline: 100 mg twice daily (adults only; avoid in children <8 years)
- Clindamycin: 300-450 mg three times daily (adults) or 20 mg/kg/day in 3 divided doses (children) - but check local resistance patterns 7, 2, 3
Common Pitfalls:
- Avoid penicillin V alone - it is seldom effective for impetigo because most cases involve S. aureus, which produces beta-lactamase 5, 6
- First-generation cephalosporins like cephalexin are appropriate, unlike what might be assumed from their spectrum - they have adequate activity against both pathogens 1, 2
- TMP-SMX covers MRSA but has inadequate streptococcal coverage - if used, consider adding a beta-lactam if streptococcal infection is likely 7, 5
Special Populations:
- Pregnant patients: Avoid doxycycline; use beta-lactams or clindamycin
- Children <8 years: Avoid tetracyclines (doxycycline, minocycline) 2, 3
The 2014 IDSA guidelines 2, 3 represent the most authoritative and recent comprehensive guidance, consistently recommending dicloxacillin or cephalexin as first-line oral therapy, with duration of approximately 7 days depending on clinical response.